Centre Hospitalier Universitaire de Nice, Hopital Pasteur 2

Nice 06001

1 studies enrolling now · 2 studies all time

What they study most

Antibody-mediated Rejection, Primary Mitochondrial Disease

Studies at this site

• Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease — Recruiting now
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early